Abstract
For biomedical applications, chitosan and oligochitosan must be appropriately characterized and meet pharmacological requirements in terms of contamination by residual heavy metals.In this work, a series of commercial chitosans was analyzed by ICP-MS method, and high concentration of Fe (44–382 ppm), Cr (3.1–35.5 ppm) and Ni (0.33–7.91 ppm) exceeding pharmacologically acceptable level was found. It was shown that as a chelating agent EDTA was an ineffective remedy for solid-phase extraction of residual heavy metals from chitosan. It was proposed that corrosion of stainless steel apparatus in the process of chitin deacetylation contributed to chitosan contamination by heavy metals. A two-step treatment of chitosan with hydrochloric acid allowed remediation of chitosan and preparation of oligochitosan hydrochloride with molecular weight 5–16 kDa and acceptable level of Fe<10, Cr<1 and Ni<1 ppm.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.